BACKGROUND¡¡¡¡Malabsorption of thyroxine has been described in patients treated with drugs that modify an acidic environment£®We determined whether there is an increased need for thyroxine in patients with euthyroid multinodular goiter and impaired secretion of gastric acid£®
METHODS¡¡¡¡We assessed the dose of thyroxine required to obtain a low level of thyrotropin(0.05 to 0.20 mU per liter)in 248 patients with multinodular goiter of these 248 patients,53 also had Heli-cobacter pylori-related gastritis and 60 had atrophic gastritis of the body of the stomach (31 with evidence of H.pylori infection and 29 without such evidence)£®The reference group comprised 135 patients with multinodular goiter and no gastric disorders£®In addition£®variation in the level of serum thyrotropin was prospectively studied in ll patients treated with thyroxine before and after H£®pylori infection and both before and during treatment with omeprazole in 10 patients treated with thyroxine who had gastroesophageal reflux£®
RESULTS¡¡¡¡The daily requirement ofthyroxine was higher(by 22 to 34 percent)in patients with H£®pylori-related gastritis£¬atrophic gastritis£®or both conditions than in the reference group£®In prospective studies£®the occurrence of H£®pylori infection in the 11 patients treated with thyroxin led to an increase in the level of serum thyrotropin(P=0.002)£¬an effect that was nearly reversed on eradication of H£®pylori infection£®In a similar way£¬omeprazole treatment was associated with an increase in the level of serum thyrotropin in all 10 patients treated with thyroxine£¬an effect that was reversed by an increase in the thyroxine dose by 37 percent£®
CONCLUSIONS¡¡¡¡Patients with inpaired acid secretion require an increased dose of thyroxine£®suggesting that normal gastric acid secretion is necessary for effeetive absorption of oral thyroxine£®
(N Engl J Med 2006£»354£º1787-95£®April 27,2006)
|